The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial
Abstract
OBJECTIVE: The opiate antagonist drug naltrexone has been shown in a few studies with limited sample sizes to be effective when combined with psychosocial therapies for the treatment of alcohol dependence. The goal of this study was to obtain additional information regarding its efficacy in pertinent alcoholic populations and with a well-defined therapy. METHOD: In this study, 131 recently abstinent alcohol-dependent outpatients were treated with 12 weekly sessions of manual-guided cognitive behavioral therapy and either 50 mg/day of naltrexone (N = 68) or placebo (N = 63) (with riboflavin added as a marker of compliance) in a double-blind, randomized clinical trial. Alcohol consumption, craving, adverse events, and urinary riboflavin levels were assessed weekly. Levels of blood markers of alcohol abuse were also ascertained during the trial. RESULTS: The study completion, therapy participation, and medication compliance rates in the trial were high, with no differences between treatment groups. Naltrexone-treated subjects drank less, took longer to relapse, and had more time between relapses. They also exhibited more resistance to and control over alcohol-related thoughts and urges, as measured by a subscale of the Obsessive Compulsive Drinking Scale. Over the study period, 62% of the naltrexone group did not relapse into heavy drinking, in comparison with 40% of the placebo group. CONCLUSIONS: Motivated individuals with moderate alcohol dependence can be treated with greater effectiveness when naltrexone is used in conjunction with weekly outpatient cognitive behavioral therapy. Naltrexone increases control over alcohol urges and improves cognitive resistance to thoughts about drinking. Thus, the therapeutic effects of cognitive behavioral therapy and naltrexone may be synergistic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
The cost effectiveness of treatment for alcoholism: a first approximation
Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991) · Journal of Studies on Alcohol · doi:10.15288/jsa.1991.52.517 · Cited by 394
Research works printed but not linked: 18
- O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992; 49:881–887 · DOI · Paper page
- Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O’Brien CP: Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 1997; 54:737–742 · DOI · Paper page
- Volpicelli JR, Watson NT, King AC, Sherman CE, O’Brien CP: Effect of naltrexone on alcohol “high” in alcoholics. Am J Psychiatry 1995; 152:613–615 · DOI · Paper page
- O’Malley SS, Jaffe AJ, Rode S, Rounsaville BJ: Experience of a “slip” among alcoholics treated with naltrexone or placebo. Am J Psychiatry 1996; 153:281–283 · DOI
- Hyytia P, Sinclair JD: Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 1993; 17:631–636 · DOI
- Weiss F, Mitchiner M, Bloom FE, Koob GF: Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology (Berl) 1990; 101:178–186 · DOI · Paper page
- O’Malley SS, Croop RS, Wroblewski JM, Labriola DF, Volpicelli JR: Naltrexone in the treatment of alcohol dependence: a combined analysis of two trials. Psychiatr Annals 1995; 25:681–688 · DOI
- Anton RF, Moak DH, Latham P: The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 1995; 19:92–99 · DOI · Paper page
- Anton RF, Moak DH, Latham PK: The Obsessive Compulsive Drinking Scale (OCDS): a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996; 53:225–231 · DOI · Paper page
- Anton RF, Moak DH, Latham P: Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res 1996; 20:841–846 · DOI
- McLellan AT, Luborsky L, Woody GE, O’Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980; 168:26–33 · DOI · Paper page
- Skinner HA, Allen BA: Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 1982; 91:199–209 · DOI · Paper page
- Sobell LC, Sobell MB, Leo CI, Cancilla A: Reliability of a timeline method: assessing normal drinkers’ reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1988; 83:393–402 · DOI · Paper page
- Fuller RK, Lee KK, Gordis E: Validity of self-report in alcoholism research: results of a Veterans Administration Cooperative Study. Alcohol Clin Exp Res 1988; 12:201–205 · DOI
- Spanagel R, Zieglgansberger W: Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997; 18:54–59 · doi:10.1016/s0165-6147(96)01026-7
- Kozlowski LT, Mann RE, Wilkinson DA, Poulos CX: “Cravings” are ambiguous: ask about urges and desires. Addict Behav 1989; 14:443–445 · DOI
- Pickens RW, Johanson C-E: Craving: consensus of status and agenda for future research. Drug Alcohol Depend 1992; 30:127–131 · DOI · Paper page
- Jaffe AJ, Rounsaville B, Chang G, Schottenfeld RS, Meyer RE, O’Malley SS: Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol 1996; 64:1044–1053 · DOI
Cited by
Room, R., Babor, T., & Rehm, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17870-2 · Cited by 1,625
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470
Metadata
- Authors
- Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K.
- Venue
- American Journal of Psychiatry
- Published
- 1999-11-01
- Volume
- 156
- Issue
- 11
- Pages
- 1758-1764
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2150715760
- Cited by
- 425
- References
- 4
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial. https://app.cochat.ai/papers/10.1176/ajp.156.11.1758
- The paper
- Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999). Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial. American Journal of Psychiatry. https://doi.org/10.1176/ajp.156.11.1758
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
